Mumbai-based Sahajanand Medical Technologies (SMT) has been selected as the exclusive distributor of US-based Penumbra’s peripheral and coronary vascular thrombectomy technologies in select domestic geographies in India.
Under the terms of the agreement, SMT will provide healthcare providers with Penumbra’s latest Indigo System portfolio, including CAT RX, which recently received India CDSCO (Central Drug Standard Control Organization) approval, and Lightning technologies, upon regulatory approval, to address conditions such as coronary thrombosis, venous thrombosis, arterial thrombosis and pulmonary embolism.
Penumbra’s Indigo System portfolio is designed for single session blood clot removal in peripheral arterial and venous systems, including the treatment of pulmonary embolism, and now with Lightning Aspiration Tubing, is the first and only computer-aided mechanical aspiration technology that can differentiate between clot and blood, which is designed to minimise blood loss. Additionally, Penumbra’s Indigo System CAT RX is designed for safe and efficient blood clot removal from the coronary and peripheral vasculature.
